Drugs / PF-07059013
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04323124 | Jul 2020 → Oct 2021 | — | Pfizer | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PF-07059013 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04323124 ↗ |
| Modality | Small molecule | — CHEMBL4650304 ↗ |
| Route | Oral | “single and multiple ascending oral doses of PF-07059013” NCT04323124 ↗ |